Status:
RECRUITING
Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
Lead Sponsor:
Centre Hospitalier de Saint-Denis
Conditions:
Drug Overdose
Metformin
Eligibility:
All Genders
18+ years
Brief Summary
This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin a...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older
- Admission to an intensive care unit (ICU) due to acute drug poisoning
- Documented exposure to either:
- Metformin alone
- Metformin in combination with dapagliflozin
Exclusion
- Patients under 18 years of age
- No exposure to metformin
- Exposure to dapagliflozin without metformin
Key Trial Info
Start Date :
April 11 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 11 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07193069
Start Date
April 11 2025
End Date
April 11 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Denis
Saint-Denis, France, France